Many AML-specific antigens (e.g., CD33, CD123, CLL-1, CD70, and TIM-3) have been explored as targets for CAR T cells, as extensively reviewed elsewhere [106]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.